References
- Dimopoulos MA, Terpos E. Multiple myeloma. Ann Oncol. 2010;21(Suppl 7):143–150.
- Kyle RA, Rajkumar SV. Multiple myeloma. Blood 2008;15(111):2962–2972.
- http://www.kanser.gov.tr/folders/file/8iL–2006-son.pdf
- Bladé J, Fernández-Llama P, Bosch F, . Renal failure in multiple myeloma: Presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998;28(158):1889–1893.
- Eleutherakis-Papaiakovou V, Bamias A, Gika D, . Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance. Leuk Lymphoma. 2007;48:337–341.
- Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: A 20-year experience from a single centre. Nephrol Dial Transplant. 2010;25:419–426.
- Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: Reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Hematol. 2000;65:175–181.
- Wirk B. Renal failure in multiple myeloma: A medical emergency. Bone Marrow Transplant. 2011;46:771–783.
- Dimopoulos MA, Kastritis E, Rosinol L, Bladé J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008;22:1485–1493.
- Kleber M, Ihorst G, Deschler B, . Detection of renal impairment as one specific comorbidity factor in multiple myeloma: Multicenter study in 198 consecutive patients. Eur J Hematol. 2009;83:519–527.
- Dimopoulos MA, Terpos E. Renal insufficiency and failure. Hematol Am Soc Hematol Educ Program. 2010;2010:431–436.
- Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842–854.
- Greipp PR, San Miguel J, Durie BG, . International staging system for multiple myeloma. J Clin Oncol. 2005;23:3412–3420.
- Durie BG, Harousseau JL, Miguel JS, . International uniform response criteria for multiple myeloma. Leukemia. 2006;20:1467–1473.
- Montseny JJ, Kleinknecht D, Meyrier A, . Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13:1438–1445.
- Cockwell P, Hutchison CA. Management options for cast nephropathy in multiple myeloma. Curr Opin Nephrol Hypertens. 2010;19:550–555.
- Hutchison CA, Harding S, Mead G, . Serum free-light chain removal by high cutoff hemodialysis: Optimizing removal and supportive care. Artif Organs. 2008;32:910–917.
- Hutchison CA, Bradwell AR, Cook M, . Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol. 2009;4:745–754.
- San-Miguel JF, Richardson PG, Sonneveld P, . Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study. Leukemia. 2008;22:842–849.
- Roussou M, Kastritis E, Migkou M, . Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens. Leuk Lymphoma. 2008;49:890–895.
- Kastritis E, Anagnostopoulos A, Roussou M, . Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Hematologica. 2007;92:546–549.
- Gertz MA, Lacy MQ, Dispenzieri A, . Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplant. 2007;39:605–611.
- Parikh GC, Amjad AI, Saliba RM, . Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009;15:812–816.
- Raab MS, Breitkreutz I, Hundemer M, . The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure. Hematologica. 2006;91:1555–1558.